Tomoki Nakamizo

1.9k total citations
35 papers, 1.6k citations indexed

About

Tomoki Nakamizo is a scholar working on Pharmacology, Neurology and Molecular Biology. According to data from OpenAlex, Tomoki Nakamizo has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in Tomoki Nakamizo's work include Cholinesterase and Neurodegenerative Diseases (6 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Nuclear Receptors and Signaling (4 papers). Tomoki Nakamizo is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (6 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Nuclear Receptors and Signaling (4 papers). Tomoki Nakamizo collaborates with scholars based in Japan, United States and Hong Kong. Tomoki Nakamizo's co-authors include Shun Shimohama, Hideyuki Sawada, Akinori Akaike, Takeshi Kihara, Kazuhiro Honda, Hiroshi Shibasaki, Rie Kanki, Makoto Urushitani, Toshiaki Kume and Hirofumi Yamashita and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tomoki Nakamizo

32 papers receiving 1.6k citations

Peers

Tomoki Nakamizo

CMN

NEURO

GENET

PHARM

Kenneth I. Strauss United States

Chun‐Hsien Chu Taiwan

Masakazu Ibi Japan

Stephan Brecht Germany

Michelle F. Anderson Sweden

Florian Plattner United States

Hyung Hwan Baik South Korea

Rita Valenzuela Spain

Nicole Mahy Spain

Kenneth I. Strauss United States

Tomoki Nakamizo

771 ×1.0

460 ×0.9

CMN

266 ×0.9

NEURO

115 ×0.4

GENET

185 ×0.7

PHARM

Citations per year, relative to Tomoki Nakamizo Tomoki Nakamizo (= 1×) peers Kenneth I. Strauss

Countries citing papers authored by Tomoki Nakamizo

Since Specialization

Citations

This map shows the geographic impact of Tomoki Nakamizo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoki Nakamizo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoki Nakamizo more than expected).

Fields of papers citing papers by Tomoki Nakamizo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoki Nakamizo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoki Nakamizo. The network helps show where Tomoki Nakamizo may publish in the future.

Co-authorship network of co-authors of Tomoki Nakamizo

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoki Nakamizo. A scholar is included among the top collaborators of Tomoki Nakamizo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoki Nakamizo. Tomoki Nakamizo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakamizo, Tomoki, John Cologne, Tetsuya Takahashi, et al.. (2024). Reliability, stability during long-term storage, and intra-individual variation of circulating levels of osteopontin, osteoprotegerin, vascular endothelial growth factor-A, and interleukin-17A. European journal of medical research. 29(1). 133–133. 1 indexed citations

Nakamizo, Tomoki, Munechika Misumi, Tetsuya Takahashi, et al.. (2023). Female “Paradox” in Atrial Fibrillation—Role of Left Truncation Due to Competing Risks. Life. 13(5). 1132–1132. 1 indexed citations

Nara, Noriko, et al.. (2023). Prolonged platelet hyperactivity after COVID‐19 infection. British Journal of Haematology. 204(2). 492–496. 4 indexed citations

Kudo, Yosuke, et al.. (2021). Bedside video-oculographic evaluation of eye movements in acute supratentorial stroke patients: A potential biomarker for hemispatial neglect. Journal of the Neurological Sciences. 425. 117442–117442. 6 indexed citations

Nakamizo, Tomoki, John Cologne, Michiko Yamada, et al.. (2021). Radiation effects on atherosclerosis in atomic bomb survivors: a cross‐sectional study using structural equation modeling. European Journal of Epidemiology. 36(4). 401–414. 5 indexed citations

Nakamizo, Tomoki, et al.. (2020). Development of a clinical score, PANDA, to predict delirium in stroke care unit. Journal of the Neurological Sciences. 415. 116956–116956. 13 indexed citations

Nakamizo, Tomoki, Masahiro Yamamoto, & Ken Johkura. (2018). Changes in stroke risk by freedom-from-stroke time in simulated populations with atrial fibrillation: Freedom-from-event effect when event itself is a risk factor. PLoS ONE. 13(3). e0194307–e0194307. 3 indexed citations

Watanabe, Kosuke, et al.. (2017). Comparative study of ipsilesional and contralesional repetitive transcranial magnetic stimulations for acute infarction. Journal of the Neurological Sciences. 384. 10–14. 44 indexed citations

Nakamizo, Tomoki & Masahiro Yamamoto. (2009). Stroke-free duration and stroke risk in patients with atrial fibrillation: simulation using a Bayesian inference.. Asian Biomedicine. 3(4). 445–450. 4 indexed citations

10.

Yamashita, Hirofumi, Jun Kawamata, Katsuya Okawa, et al.. (2007). Heat‐shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide dismutase: clues to a possible strategy for treating ALS. Journal of Neurochemistry. 102(5). 1497–1505. 44 indexed citations

11.

Ueda, Toshihiro, Atsushi Itoh, Arata Abe, et al.. (2006). Therapeutic strategy of revascularization for acute ischemic stroke after approval of intravenous rt-PA. Nosotchu. 28(4). 633–639. 2 indexed citations

12.

Kihara, Takeshi, Hideyuki Sawada, Tomoki Nakamizo, et al.. (2004). Galantamine modulates nicotinic receptor and blocks Aβ-enhanced glutamate toxicity. Biochemical and Biophysical Research Communications. 325(3). 976–982. 99 indexed citations

13.

Kanki, Rie, Tomoki Nakamizo, Hirofumi Yamashita, et al.. (2004). Effects of mitochondrial dysfunction on glutamate receptor-mediated neurotoxicity in cultured rat spinal motor neurons. Brain Research. 1015(1-2). 73–81. 50 indexed citations

14.

Sawada, Hideyuki, Ryuichi Kohno, Takeshi Kihara, et al.. (2004). Proteasome Mediates Dopaminergic Neuronal Degeneration, and Its Inhibition Causes α-Synuclein Inclusions. Journal of Biological Chemistry. 279(11). 10710–10719. 96 indexed citations

15.

Nakamizo, Tomoki, Jun Kawamata, Yuko Kawai, et al.. (2002). Phosphodiesterase inhibitors are neuroprotective to cultured spinal motor neurons. Journal of Neuroscience Research. 71(4). 485–495. 53 indexed citations

16.

Sawada, Hideyuki, Masakazu Ibi, Takeshi Kihara, et al.. (2002). Estradiol protects dopaminergic neurons in a MPP+Parkinson’s disease model. Neuropharmacology. 42(8). 1056–1064. 100 indexed citations

17.

Kihara, Takeshi, Shun Shimohama, Hideyuki Sawada, et al.. (2002). Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade. Journal of Neuroscience Research. 70(3). 274–282. 83 indexed citations

18.

Nakamizo, Tomoki, Haruhisa Inoue, Fukashi Udaka, et al.. (2002). Magnetic Resonance Imaging of Primary Spinal Intramedullary Lymphoma. Journal of Neuroimaging. 12(2). 183–186. 20 indexed citations

19.

Nakamizo, Tomoki, Makoto Urushitani, Ryotaku Inoue, et al.. (2000). Protection of cultured spinal motor neurons by estradiol. Neuroreport. 11(16). 3493–3497. 67 indexed citations

20.

Urushitani, Makoto, Ryotaku Inoue, Tomoki Nakamizo, et al.. (2000). Neuroprotective effect of cyclic GMP against radical-induced toxicity in cultured spinal motor neurons. Journal of Neuroscience Research. 61(4). 443–448. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact